Neuropsychopharmacology renaissance in Japan: A new era after the crisis

Psychiatry Clin Neurosci. 2023 Jul;77(7):375-376. doi: 10.1111/pcn.13549. Epub 2023 Apr 13.

Authors

Norio Ozaki¹, Teiji Kimura², Tetsuro Kikuchi³, Takeo Ishiyama⁴

Affiliations

¹ Pathophysiology of Mental Disorders, Nagoya University Graduate School of Medicine, Nagoya, Japan.
² Eisai Co., Ltd., Tokyo, Japan.
³ Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
⁴ Drug Research Division, Sumitomo Pharma Co., Ltd., Osaka, Japan.

PMID: 37052366
DOI: 10.1111/pcn.13549

No abstract available

Publication types

Editorial

MeSH terms

Humans
Japan
Psychopharmacology*

Grants and funding

JP22dk0307113/AMED